Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

被引：111
|
作者：
Choo, Eun Ju [1 ]
Chambers, Henry F. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Med, Div Infect Dis, Bucheon, South Korea
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA
来源：
INFECTION AND CHEMOTHERAPY | 2016年 / 48卷 / 04期
关键词：
Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment;
D O I：
10.3947/ic.2016.48.4.267
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
引用
收藏
页码：267 / 273
页数：7
相关论文
共 50 条
  • [21] Bacterial factors influencing the mortality for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia
    Zarakolu, Pinar
    Metan, Gokhan
    Karahan, Zeynep Ceren
    Tekeli, Alper
    Unal, Serhat
    INFECTIOUS DISEASES, 2016, 48 (08) : 649 - 650
  • [22] Methicillin-Resistant Staphylococcus aureus Infections
    Pottinger, Paul S.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (04) : 601 - +
  • [23] Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia
    Neuner, Elizabeth A.
    Casabar, Ed
    Reichley, Richard
    McKinnon, Peggy S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 67 (03) : 228 - 233
  • [24] A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia
    Jorgensen, Sarah C. J.
    Lagnf, Abdalhamid M.
    Bhatia, Sahil
    Rybak, Michael J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (05) : 843 - 850
  • [25] Bacteremia due to Methicillin-Resistant Staphylococcus aureus An Update on New Therapeutic Approaches
    Holubar, Marisa
    Meng, Lina
    Alegria, William
    Deresinski, Stan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2020, 34 (04) : 849 - +
  • [26] Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Kaye, Keith S.
    Patel, Twisha
    Drusano, George
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [27] Methicillin-resistant Staphylococcus aureus: the superbug
    Ippolito, Giuseppe
    Leone, Sebastiano
    Lauria, Francesco N.
    Nicastri, Emanuele
    Wenzel, Richard P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S7 - S11
  • [28] Microbiological and genotypic factors affecting mortality in methicillin-resistant Staphylococcus aureus bacteremia
    Joo, Eun-Jeong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (01) : 63 - 64
  • [29] Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
    Guthridge, Isabel
    Smith, Simon
    Law, Matthew
    Binotto, Enzo
    Hanson, Josh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (09)
  • [30] Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
    Yamada, Koichi
    Yanagihara, Katsunori
    Hara, Yukiko
    Araki, Nobuko
    Harada, Yousuke
    Morinaga, Yoshitomo
    Matsuda, Junichi
    Izumikawa, Koichi
    Seki, Masafurni
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Kohno, Shigeru
    Kamihira, Shimeru
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 224 (01) : 61 - 67
12345